Evidence map›Paper›PMID 42137652›Full record

ArticleCureus2026

Transvenous Embolization of Olfactory Groove Dural Arteriovenous Fistula: A Case Series of Three Patients.

Amir Nazari, Michihiro Tanaka, Kotaro Ueda, Takafumi Mitsutake, Keisuke Kadooka

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amir NazariDepartment of Neurological Surgery, International School of Medicine, Istanbul Medipol University, Istanbul, TUR.
Michihiro TanakaDepartment of Neuroendovascular Surgery, Kameda Medical Center, Kamogawa, JPN.
Kotaro UedaDepartment of Neuroendovascular Surgery, Kameda Medical Center, Kamogawa, JPN.
Takafumi MitsutakeDepartment of Neuroendovascular Surgery, Kameda Medical Center, Kamogawa, JPN.
Keisuke KadookaDepartment of Neuroendovascular Surgery, Kameda Medical Center, Kamogawa, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Olfactory groove or anterior cranial fossa (ACF) dural arteriovenous fistulas (DAVFs) are rare but highly aggressive lesions because of their direct cortical venous drainage and high risk of intracranial hemorrhage. Transarterial embolization (TAE) is commonly considered the first-line treatment; however, anatomical complexity or arterial limitations may make TAE technically difficult or unsafe. We present a case series of three patients with olfactory groove DAVFs successfully treated using transvenous embolization (TVE). In all cases, the fistulous point was accessed through the superior sagittal sinus and cortical bridging veins, allowing targeted coil embolization of the draining vein. Complete angiographic obliteration was achieved in all patients. One patient developed neurological deficits related to a thromboembolic event during arterial catheterization, while the remaining two patients had uneventful recoveries. Our experience suggests that TVE can be a feasible and effective treatment option for selected olfactory groove DAVFs, particularly in cases where arterial access is challenging or when previous transarterial treatment has failed.

Indexed as

anterior cranial fossadural arteriovenous fistulaendovascular treatmentolfactory groovetransvenous embolization

Identifiers

PMID42137652
PMCPMC13170405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.